BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kogure T, Ueno Y, Fukushima K, Nagasaki F, Kondo Y, Inoue J, Matsuda Y, Kakazu E, Yamamoto T, Onodera H, Miyazaki Y, Okamoto H, Akahane T, Kobayashi T, Mano Y, Iwasaki T, Ishii M, Shimosegawa T. Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan. World J Gastroenterol 2008; 14(47): 7225-7230 [PMID: 19084938 DOI: 10.3748/wjg.14.7225]
URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7225.htm
Number Citing Articles
1
Junichi Shindoh, Kiyoshi Hasegawa, Yutaka Matsuyama, Yosuke Inoue, Takeaki Ishizawa, Taku Aoki, Yoshihiro Sakamoto, Yasuhiko Sugawara, Masatoshi Makuuchi, Norihiro Kokudo. Low Hepatitis C Viral Load Predicts Better Long-Term Outcomes in Patients Undergoing Resection of Hepatocellular Carcinoma Irrespective of Serologic Eradication of Hepatitis C VirusJournal of Clinical Oncology 2013; 31(6): 766 doi: 10.1200/JCO.2012.44.3234
2
Matteo Garcovich, Andrew Kenneth Burroughs. Sex and Gender Aspects in Clinical Medicine2012; : 65 doi: 10.1007/978-0-85729-832-4_6
3
Yoshiyuki Ueno. The Current Endeavors to Understand the Pathogenesis of Intractable Liver DiseasesThe Tohoku Journal of Experimental Medicine 2012; 226(3): 171 doi: 10.1620/tjem.226.171
4
Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi, Masatoshi Kudo. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)Hepatology Research 2010; 40(4): 347 doi: 10.1111/j.1872-034X.2010.00642.x
5
S. K. Tohra, S. Taneja, S. Ghosh, B. K. Sharma, A. Duseja, R. K. Dhiman, A. Das, Y. K. Chawla. Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis CDigestive Diseases and Sciences 2011; 56(8): 2449 doi: 10.1007/s10620-011-1770-3
6
Daigo Kon, Takashi Goto, Kouichi Miura, Shigetoshi Ohshima, Tomomi Shibuya, Ei Kataoka, Wataru Sato, Takahiro Dohmen, Yumiko Anezaki, Hajime Ishii, Ikuhiro Yamada, Kentaro Kamada, Hirohide Ohnishi. Three Patients with Viral Breakthrough during Pegylated Interferon Alpha-2b and Ribavirin Therapy: A Case SeriesClinical Medicine. Gastroenterology 2011; 4: CGast.S6264 doi: 10.4137/CGast.S6264
7
Shuhei Nishiguchi, Namiki Izumi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshito Ito, Yasuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi, Masatoshi Kudo. JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis CKanzo 2009; 50(11): 665 doi: 10.2957/kanzo.50.665
8
Shuhei Nishiguchi, Hirayuki Enomoto, Nobuhiro Aizawa, Hiroki Nishikawa, Yukio Osaki, Yasuhiro Tsuda, Kazuhide Higuchi, Kazuichi Okazaki, Toshihito Seki, Soo Ryang Kim, Yasushi Hongo, Hisato Jyomura, Naoshi Nishida, Masatoshi Kudo. Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J studyJournal of Gastroenterology 2014; 49(3): 492 doi: 10.1007/s00535-013-0785-2
9
Mohamed A Daw, Hana A Elasifer, Aghnaya A Dau, Mohamed Agnan. The role of hepatitis C virus genotyping in evaluating the efficacy of INF-based therapy used in treating hepatitis C infected patients in LibyaVirology Discovery 2013; 1(1): 3 doi: 10.7243/2052-6202-1-3
10
Kazuaki Chayama, C. Nelson Hayes, Kentaro Yoshioka, Hisataka Moriwaki, Takeshi Okanoue, Shotaro Sakisaka, Tetsuo Takehara, Makoto Oketani, Joji Toyota, Namiki Izumi, Yoichi Hiasa, Akihiro Matsumoto, Hideyuki Nomura, Masataka Seike, Yoshiyuki Ueno, Hiroshi Yotsuyanagi, Hiromitsu Kumada. Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis CHepatology Research 2010; 40(12): 1155 doi: 10.1111/j.1872-034X.2010.00726.x
11
Yasuhiro Asahina, Namiki Izumi, Makoto Oketani, Hiromitsu Kumada, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu, Hiroshi Yotsuyanagi. Treatment Guidelines of Hepatitis CKanzo 2012; 53(6): 355 doi: 10.2957/kanzo.53.355
12
Yoshisato Tanimoto, Hirotaka Tashiro, Hiroshi Aikata, Hironobu Amano, Akihiko Oshita, Tsuyoshi Kobayashi, Shintaro Kuroda, Hirofumi Tazawa, Shoichi Takahashi, Toshiyuki Itamoto, Kazuaki Chayama, Hideki Ohdan. Impact of Pegylated Interferon Therapy on Outcomes of Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma After Curative Hepatic ResectionAnnals of Surgical Oncology 2012; 19(2): 418 doi: 10.1245/s10434-011-1866-1
13
Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon, Roberto José Carvalho-Filho, Juliana Peghini Sampaio, Philipe Nicolas El Batah, Denize Vieira Barbosa, Maria Lucia Gomes Ferraz, Antonio Eduardo Benedito Silva. Gender influence on treatment of chronic hepatitis C genotype 1Revista da Sociedade Brasileira de Medicina Tropical 2010; 43(3): 217 doi: 10.1590/S0037-86822010000300001
14
H. Ochi, C. N. Hayes, H. Abe, Y. Hayashida, T. Uchiyama, N. Kamatani, Y. Nakamura, K. Chayama. Toward the Establishment of a Prediction System for the Personalized Treatment of Chronic Hepatitis CJournal of Infectious Diseases 2012; 205(2): 204 doi: 10.1093/infdis/jir726
15
Guidelines for the Management of Hepatitis C Virus InfectionHepatology Research 2013; 43(1): 1 doi: 10.1111/hepr.12020
16
Varun Gupta, Ashish Kumar, Praveen Sharma, Pankaj Tyagi, Naresh Bansal, Vikas Singla, Anil Arora. Sustained Virological Response Rates to Antiviral Therapy in Genotype 1 and 3 Chronic Hepatitis C Patients: A Study from North IndiaJournal of Clinical and Experimental Hepatology 2014; 4(4): 287 doi: 10.1016/j.jceh.2014.08.004